AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $58.95
- 52-wk high
- $64.38
- High
- $59.54
- 52-wk low
- $33.97
- Low
- $58.35
- Prev close
- $58.75
- Mkt cap
- $33.87B
- P/E
- 31.5x
- Volume
- 2.60M
- Fwd P/E
- 29.9x
- Beta
- 0.43
- Div yield
- 1.55%
- P/S
- 13.3x
- P/B
- 3.8x
- Profit margin
- +32.0%
- Op margin
- +19.8%
- ROE
- +14.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 3.9% above what analysts expected.
Earnings per share
$1.27 expected
Revenue
$758.9M expected
The release did not provide a source-backed EPS figure.
FY2026 guidance
$3.40B to $3.50B
No comparable estimate
Reports Nov 4, 2026, in 52 days
EPS expected
$1.14 to $1.22
Revenue expected
4 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $609.3M | $622.0M | $630.6M | $674.1M |
| Cost of what it sold | $1.3M | $1.2M | $1.2M | $268.2M |
| Gross profit | $609.3M | $622.0M | $629.4M | $405.9M |
| What it spent | ||||
| Research and development | $50.5M | $51.0M | $40.0M | $97.9M |
| Sales and admin | $118.7M | $164.3M | $159.0M | $161.9M |
| Other operating costs | $12.9M | $18.3M | -$202.1M | $13.1M |
| Total operating expenses | $182.1M | $233.6M | -$3.1M | $272.8M |
| What was left | ||||
| Operating profit | $427.2M | $388.4M | $632.5M | $133.0M |
| Interest on debt | $79.6M | $94.2M | $93.7M | $93.6M |
| Profit before tax | $444.2M | $355.9M | $468.3M | $81.5M |
| Tax | $156.0M | $142.0M | $173.0M | — |
| Net profit | $288.2M | $214.2M | $295.0M | $17.9M |
| EBITDA | $525.1M | $451.3M | $563.1M | $176.4M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
45 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week High - What's Next?
Leans bullishSep 1Headlands Technologies LLC Invests $5.09 Million in Royalty Pharma PLC $RPRX
Leans bullishAug 31
Macro
10 macro signals shaping RPRX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results